Anticoagulation Monitoring Devices Market Size, Share & Industry Analysis, By Device Type (PT-INR Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPTT)), By End-user (Hospitals & Clinics, Homecare, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113537

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 7.2% from 2025-2032
Unit	Value (USD Billion)
Segmentation	By Device Type PT-INR Testing Devices Activated Clotting Time (ACT) Activated Partial Thromboplastin Time (aPTT)
	By End-user Hospitals & Clinics Homecare Others
	By Region North America (By Device Type, End-user, and Country) U.S. Canada Europe (By Device Type, End-user, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Device Type, End-user, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Device Type, End-user, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Device Type, End-user, and Country/Sub-region) GCC South Africa Middle East & Africa